ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 46

Synovitis in Secondary Osteoarthritis Due to Rheumatoid Arthritis: A Proof-of-Concept Study

Stefan Vordenbäumen1, Tim Lögters2, Philipp Sewerin1, Thomas Pauly3, Ellen Bleck4, Paulina Philippski1, Matthias Schneider1, Michael Schädel-Höpfner2 and Benedikt Ostendorf1, 1Endocrinology, Diabetology and Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany, 2Trauma and Hand Surgery, Heinrich-Heine-University, Düsseldorf, Germany, 3Orthopaedics, Rheinisches Rheumazentrum St. Elisabeth-Hospital, Meerbusch, Germany, 4Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis, rheumatoid arthritis (RA) and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint

Session Type: Abstract Submissions (ACR)

Background/Purpose: Rheumatoid arthritis (RA) is characterized by considerable synovial inflammation which may result in secondary osteoarthritis (sOA). Primary OA (pOA) occurs in patients without predisposing disorders such as RA and displays varying degrees of synovial inflammation. Although it is conceivable that a major structural difference between sOA due to RA and pOA consists in synovial histology, direct research on such histological differences is limited. Moreover, the search for suitable biomarkers to distinguish OA subtypes is considered an important step in the search for medical treatments. We therefore investigated if synovitis in patients with sOA due to RA is different from pOA, and if it more closely resembles active RA.

Methods: Synovial tissue was collected and snap frozen at time of joint replacement in patients with (1) pOA (n = 8, hip), (2) sOA (defined as RA according to ACR/EULAR criteria plus OA in accordance with 2009 EULAR recommendations for diagnosis of knee OA (n = 4) or 1991 ACR criteria for hip OA (n = 3)), and (3) active RA without any signs of OA (n = 8 metacarpophalangeal joints; mean DAS28 5.2 ± 1.4) by arthroscopically guided biopsy or open synovectomy. Hematoxylin and eosin stained sections were used for determination of the Synovitis Score according to Krenn. Immunohistochemically stained sections were used for semiquantitative scoring or digital image analysis (% stained area) of CD68+ macrophages in a blinded fashion. Comparison of groups was by Kruskal-Wallis Test and Dunn’s posthoc test. Correlations between methods of CD68 scoring were according to Spearman.

Results: High-grade synovitis was revealed by conventional histology in patients with sOA and RA (median scores: 6), but not in pOA where mild synovitis was predominant (median score 3; p = 0.012). This was largely due to the subscore on the inflammatory infiltrate with median scores of 3, 2, and 1 in sOA, RA, and pOA, respectively (p = 0.006), rather than subscores for lining layer hypertrophy (2, 2, 2.5; p = 0.013) or density of resident cells (1, 1.5, 2; p = 0.52). There was good agreement between semiquantitative scoring and digital image analysis for CD68 in all compartments (Spearman’s R 0.85, 0.8, and 0.7 with p < 0.001 for lining, sublining, and total CD68 scoring, respectively). Significant differences between groups were observed in all compartments with the strongest effect in sublining CD68 staining (median stained area 35.6% vs. 15.3% and 2.9% in sOA, RA, and pOA; p = 0.0031). The difference to sOA in sublining CD68 staining was significant after posthoc analysis for pOA, but not RA. Receiver Operating Characteristic analysis confirmed sublining CD68 staining as an excellent marker to distinguish sOA due to RA from pOA (p = 0.026, AUC 0.96, LR 8).

Conclusion: Synovial tissue analysis reveals considerable inflammation in sOA due to RA. Both conventional histology and CD68 staining confirm that sOA is histologically distinct from pOA and more closely resembles active RA. Sublining CD68 is a suitable biomarker to distinguish both OA entities.


Disclosure:

S. Vordenbäumen,
None;

T. Lögters,
None;

P. Sewerin,
None;

T. Pauly,
None;

E. Bleck,
None;

P. Philippski,
None;

M. Schneider,
None;

M. Schädel-Höpfner,
None;

B. Ostendorf,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovitis-in-secondary-osteoarthritis-due-to-rheumatoid-arthritis-a-proof-of-concept-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology